Zevra Therapeutics Inc.
Ownership
Ownership Structure
Who owns Zevra Therapeutics Inc. (ZVRA)? This page shows the largest institutions and funds, the ownership structure and the latest insider transactions. 90.7% of the shares are freely tradable; institutional investors hold 71.8%.
Largest Shareholders
Institutions
| Name | Stake (%) | Shares | Change (%) | Date |
|---|---|---|---|---|
| BlackRock Inc | 8.60 | 5,108,871 | +14.6 | 06/30/2026 |
| FMR Inc | 8.28 | 4,915,717 | +53.0 | 06/30/2026 |
| Woodline Partners LP | 8.06 | 4,785,771 | +38.7 | 06/30/2026 |
| Nantahala Capital Management, LLC | 6.05 | 3,594,952 | +42.5 | 06/30/2026 |
| Vanguard Capital Management, LLC | 4.44 | 2,638,910 | +6.9 | 06/30/2026 |
| State Street Corp | 2.83 | 1,681,999 | +7.7 | 06/30/2026 |
| Geode Capital Management, LLC | 2.59 | 1,540,936 | +12.3 | 06/30/2026 |
Funds
| Name | Stake (%) | Shares | Change (%) | Date |
|---|---|---|---|---|
| Fidelity Contrafund | 4.95 | 2,939,802 | +0.0 | 08/31/2026 |
| Vanguard MStar Total Stk Mkt Idx Invest | 3.20 | 1,899,706 | +0.0 | 09/30/2026 |
| iShares Russell 2000 ETF | 2.49 | 1,480,694 | -0.4 | 10/29/2026 |
Largest reported positions according to regulatory filings; stake as a percentage of shares outstanding, change versus the previous filing. Source: fundamentals data.
Insider holdings
| Person | Role | Shares | Value | As of | Type |
|---|---|---|---|---|---|
| McFarlane Neil F. | President and CEO | 417,225 | 4,297,418 $ | Oct 12, 2026 | direct |
| Thompson Rahsaan | Chief Legal & Compliance | 37,569 | 386,961 $ | Aug 14, 2026 | direct |
| Watton Corey Michael | Director | 1,800 | 18,540 $ | Aug 10, 2026 | direct |
Holdings as of each person's most recent SEC Form 4 filing — excluding options and RSUs, which are not shares yet. Holdings may have changed between two filings.
Insiders
Insider Transactions
| Date | Person | Role | Type | Shares | Price | Value |
|---|---|---|---|---|---|---|
| Oct 12, 2026 | McFarlane Neil F. | President and CEO | Sell | 20,000 | 11.25 | 224,948 |
| Oct 10, 2026 | McFarlane Neil F. | President and CEO | Other | 50,000 | – | – |
| Aug 14, 2026 | Thompson Rahsaan | Chief Legal & Compliance | Sell | 42,666 | 11.13 | 474,774 |
| Aug 10, 2026 | Watton Corey Michael | Director | Sell | 12,300 | 11.25 | 138,377 |
| Aug 10, 2026 | Watton Corey Michael | Director | Other | 12,300 | 4.97 | 61,131 |
Reportable transactions by officers and major shareholders from SEC Form 4 filings. "Other" includes things like stock grants and option exercises without a buy/sell character. View all insider transactions →
Data as of: October 30, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.